Latest news

InsightsMay 14, 2026

What Happens When AI Becomes a Scientific Co-Pilot?

Executive Summary Artificial intelligence is rapidly evolving from a background automation tool into an active scientific co-pilot capable of supporting...

InsightsMay 14, 2026

Digital Twins in Healthcare: Hype, Reality, and Future Applications

Executive Summary Digital twins are emerging as one of the most strategically significant — and heavily debated — innovations in...

InsightsMay 14, 2026

How Pharmaceutical Companies Are Using AI for Faster Regulatory Submissions

Executive Summary Pharmaceutical companies are increasingly using artificial intelligence to accelerate regulatory submissions, improve compliance workflows, and reduce the operational...

CommercialMay 14, 2026

Novo Pens Deal With Cellular Intelligence to Advance Parkinson’s Cell Therapy

Over six months after Novo Nordisk withdrew from the cell therapy sector, its Parkinson’s disease program appears to have...

ManufacturingMay 14, 2026

Daiichi Revises ADC Supply Plans After Changes in Cancer Drug Demand Forecasts

Daiichi Sankyo said changes in projected demand for several...

ClinicalMay 14, 2026

Lilly Studies Show Weight Loss Maintenance After Switching to Foundayo or Lower-Dose Zepbound

Patients who moved from higher-dose injectable incretin therapies to...

InsightsMay 12, 2026

5 Life Sciences Trends Defining the Next Decade of Healthcare Innovation

Executive Summary The life sciences industry is entering a transformative decade driven by artificial intelligence, precision medicine, digital health infrastructure,...

InsightsMay 12, 2026

Can AI Reduce Drug Development Costs Without Increasing Risk?

Executive Summary Yes—AI can reduce drug development costs without proportionally increasing risk, but only when deployed within structured scientific, regulatory,...

ClinicalMay 12, 2026

Inhibrx Reports Higher Response Rate for INBRX-106 and Keytruda in Midphase Head and Neck Cancer Trial

Inhibrx Biosciences reported interim data from the phase 2 portion of its HexAgon study showing a higher objective response...

RegulatoryMay 12, 2026

Biogen and Eisai were slapped with a three-month delay in beginning SubQ Alzheimer’s treatment

SubQ Biogen and Eisai could be forced to wait...

InsightsMay 11, 2026

Top 10 Skills Every Life Sciences Professional Needs in 2026

Executive Summary The life sciences industry in 2026 is undergoing...

InsightsMay 11, 2026

How Are Life Sciences Companies Reducing Environmental Impact Across Supply Chains?

Executive Summary Life sciences companies are reducing environmental impact across supply chains in 2026 by redesigning sourcing, manufacturing, and distribution...

InsightsMay 11, 2026

How Is Generative AI Changing Drug Discovery in 2026?

Executive Summary Generative AI is fundamentally reshaping drug discovery in 2026 by shifting the process from iterative, lab-driven experimentation to...

InsightsMay 11, 2026

The Rise of AI-Powered Clinical Trials: What Pharma Leaders Need to Know

Executive Summary AI-powered clinical trials are becoming a core operational strategy across pharma and biotech in 2026. Artificial intelligence is...